High Vista Strategies LLC Biomea Fusion, Inc. Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $814,416 - $1.57 Million
37,600 New
37,600 $825,000
Q2 2022

Aug 15, 2022
BUY
$3.0 - $12.03 $95,427 - $382,662
31,809 Added 28.17%
144,727 $1.73 Million
Q1 2022

May 16, 2022
BUY
$4.39 - $9.03 $495,710 - $1.02 Million
112,918 New
112,918 $504,000

Others Institutions Holding BMEA

# of Institutions
108
Shares Held
17.9M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $123M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email